Short Interest in Sonova Holding (OTCMKTS:SONVY) Declines By 94.2%

Sonova Holding (OTCMKTS:SONVY) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totaling 3,402 shares, a decrease of 94.2% from the May 31st total of 58,424 shares. Based on an average trading volume of 40,770 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are sold short.

Sonova Trading Down 0.2%

Shares of OTCMKTS SONVY traded down $0.12 during midday trading on Friday, reaching $47.93. 22,393 shares of the company’s stock traded hands, compared to its average volume of 23,183. The stock’s 50 day simple moving average is $48.59 and its 200-day simple moving average is $49.88. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43. Sonova has a one year low of $42.26 and a one year high of $61.09.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on SONVY shares. BNP Paribas Exane upgraded Sonova from a “strong sell” rating to a “strong-buy” rating in a research report on Tuesday, March 10th. Morgan Stanley upgraded shares of Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday. Citigroup reiterated a “sell” rating on shares of Sonova in a report on Wednesday, May 13th. Finally, Jefferies Financial Group downgraded shares of Sonova from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, March 18th. Two equities research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.